These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 11769864
1. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Suntharalingam M, Haas ML, Sonett JR, Doyle LA, Hausner PF, Schuetz J, Greenwald B, Krasna MJ. Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864 [Abstract] [Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179 [Abstract] [Full Text] [Related]
6. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP. Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [Abstract] [Full Text] [Related]
7. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546 [Abstract] [Full Text] [Related]
8. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Am J Surg; 2005 Jan 01; 189(1):98-109. PubMed ID: 15701501 [Abstract] [Full Text] [Related]
10. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Prenzel KL, König A, Schneider PM, Schnickmann C, Baldus SE, Schröder W, Bollschweiler E, Dienes HP, Mueller RP, Izbicki JR, Hölscher AH. Ann Surg Oncol; 2007 Feb 01; 14(2):954-9. PubMed ID: 17103071 [Abstract] [Full Text] [Related]
11. Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement. Boonstra JJ, Koppert LB, Wijnhoven BP, Tilanus HW, Van Dekken H, Tran TC, Van der Gaast A. J Surg Oncol; 2009 Oct 01; 100(5):407-13. PubMed ID: 19653239 [Abstract] [Full Text] [Related]
12. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Chen G, Wang Z, Liu XY, Zhang MY, Liu FY. Eur J Cardiothorac Surg; 2009 Jan 01; 35(1):1-7. PubMed ID: 18926712 [Abstract] [Full Text] [Related]
13. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A, Ogino T. Radiother Oncol; 2009 Aug 01; 92(2):266-9. PubMed ID: 18952308 [Abstract] [Full Text] [Related]
14. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy. Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP. J Surg Oncol; 2010 Aug 01; 102(2):158-62. PubMed ID: 20648587 [Abstract] [Full Text] [Related]
15. Optimal treatment for localized esophageal cancer still uncertain. Lord RV. Am J Gastroenterol; 2000 Jan 01; 95(1):305-7. PubMed ID: 10638607 [Abstract] [Full Text] [Related]
16. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851 [Abstract] [Full Text] [Related]
17. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Cancer; 2008 Mar 15; 112(6):1239-46. PubMed ID: 18224663 [Abstract] [Full Text] [Related]
18. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, Gu XZ, Zhang DC, Sun KL, Chen GY, He J. Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):82-90. PubMed ID: 15850906 [Abstract] [Full Text] [Related]
19. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision. Girvin GW, Matsumoto GH, Bates DM, Garcia JM, Clyde JC, Lin PH. Am J Surg; 1995 May 01; 169(5):557-9. PubMed ID: 7747839 [Abstract] [Full Text] [Related]
20. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Ann Surg Oncol; 2008 Jan 01; 15(1):104-16. PubMed ID: 17891442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]